Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15879986 | 0.81 | TSHR (0.31) | TSHR | |
| SCHEMBL15880773 | 0.80 | TSHR (0.33) | TSHRGAAKMT2A | |
| SCHEMBL28069158 | 0.76 | ALDH1A1 (0.36) | TSHRGAA | |
| SCHEMBL5551604 | 0.74 | GAA (0.40) | GAA | |
| SCHEMBL15880466 | 0.72 | — | — | |
| SCHEMBL225193 | 0.70 | GAA (0.49) | TSHRGAAKMT2A | |
| SCHEMBL8170444 | 0.70 | — | — | |
| SCHEMBL5074349 | 0.70 | TSHR (0.34) | TSHRGAAKMT2A | |
| SCHEMBL11428071 | 0.70 | HCAR2 (0.51) | TSHRGAAKMT2A | |
| SCHEMBL5315790 | 0.70 | GAA (0.36) | TSHRGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2769998-B1 | (METH)ACRYLATE COMPOUND, AND PHOTOCHROMIC CURABLE COMPOSITION CONTAINING SAID (METH)ACRYLATE COMPOUND | TOKUYAMA CORP (JP) | 2016-08-03 | — | — | EP | disclosed |
| EP-2769998-A1 | (METH)ACRYLATE COMPOUND, AND PHOTOCHROMIC CURABLE COMPOSITION CONTAINING SAID (METH)ACRYLATE COMPOUND | Tokuyama Corporation (JP) | 2014-08-27 | — | — | EP | disclosed |
| US-20140203226-A1 | (METH)ACRYLATE COMPOUND AND PHOTOCHROMIC CURABLE COMPOSITION CONTAINING THE (METH)ACRYLATE COMPOUND | TOKUYAMA CORPORATION (JP) | 2014-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140203226-A1 | (METH)ACRYLATE COMPOUND AND PHOTOCHROMIC CURABLE COMPOSITION CONTAINING THE (METH)ACRYLATE COMPOUND | TET1, MGMT, CRYAA | TSHR 807/4885GAA 4630/4885KMT2A 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.